medalphabetМедицинский алфавитMedical alphabet2078-56312949-2807ООО «Альфмед»10.33667/2078-5631-2024-21-57-62medalphabet-3957Research ArticleСтатьиВарианты стойкой обонятельной дисфункции, ассоциированной с новой коронавирусной инфекцией, и результаты леченияVariants of persistent olfactory dysfunction associated with Novel Coronavirus infection and treatment resultsАдамоваА. С.AdamovaA. S.

Адамова Анастасия Сергеевна - аспирант III года обучения на кафедре неврологии имени академика С.Н. Давиденкова.

Санкт-Петербург

Anastasia S. Adamova - 3rd year postgraduate student at Dept of Neurology n. a. academician S.N. Davidenkov.

Saint Petersburg

adamowa.anastasya@yandex.ruhttps://orcid.org/0000-0001-6814-0454КлочеваЕ. Г.KlochevaE. G.

Клочева Елена Георгиевна - д. м. н., проф.

Санкт-Петербург

Elena G. Klocheva - DM Sci (habil.), professor.

Saint Petersburg

klocheva@mail.ruhttps://orcid.org/0000-0001-9245-8067ГолдобинВ. В.GoldobinV. V.

Голдобин Виталий Витальевич - д. м. н., зав. кафедрой неврологии имени академика С.Н. Давиденкова.

Санкт-Петербург

Vitaly V. Goldobin - DM Sci (habil.), head of Dept of Neurology n. a. academician S.N. Davidenkov.

Saint Petersburg

vitalii.goldobin@szgmu.ruФГБОУ ВО «Северо-Западный государственный медицинский университет им. И.И. Мечникова» Минздрава РоссииРоссияNorth-Western State Medical University n. a. I.I. MechnikovRussian Federation202408112024021Неврология и психиатрия (3)5762Copyright © Адамова А.С., Клочева Е.Г., Голдобин В.В., 20242024Адамова А.С., Клочева Е.Г., Голдобин В.В.Adamova A.S., Klocheva E.G., Goldobin V.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-alphabet.com/jour/article/view/3957

Проблема возникновения стойкой обонятельной дисфункции (ОД), ассоциированной с новой коронавирусной инфекцией (COVID-19), в настоящее время приобрела актуальное значение, однако регламентированного стандарта терапии не разработано. По данным литературы, около 60 % пациентов отмечают наличие обонятельных нарушений, сохраняющихся от нескольких месяцев и более после выздоровления от COVID-19. Однако за медицинской помощью по поводу обонятельных нарушений обращается не более 5 %, что обозначает значимость проблемы и необходимость лечения в условиях поликлинического звена. В настоящее время используются два основных направления лечения количественных и качественных нарушений обоняния – медикаментозная и немедикаментозная терапия. В статье предложен вариант систематизации на базе существующих методов лечения с оценкой их эффективности. Описана методика выполнения обонятельной тренировки, а также представлены результаты лечения стойкой ОД.

The problem of the occurrence of persistent olfactory dysfunction (OD) associated with Novel Coronavirus infection (COVID-19) has now become relevant, however, a regulated standard of therapy has not been developed. According to the literature, about 60 % of patients report the presence of olfactory disorders that persist for several months or more after recovery from COVID-19. However, no more than 5 % seek medical help for olfactory disorders, which indicates the importance of the problem and the need for treatment in a polyclinic setting. Currently, two main areas of treatment for quantitative and qualitative disorders of the sense of smell are used – drug and non-drug therapy. The article proposes a systematization option based on existing treatment methods with an assessment of their effectiveness. The method of performing olfactory training is described, and the results of treatment of persistent OD are presented.

стойкая обонятельная дисфункцияCOVID-19Sniffin’ Stick тестинтраназальные кортикостероидысульфат цинкавитамин Ацитрат натрияинтраназальный инсулинобонятельная тренировкаpersistent olfactory dysfunctionCOVID-19Sniffin' Sticks TestIntranasal CorticosteroidsZinc Sulfatevitamin ASodium citrateIntranasal insulinolfactory trainingReferencesKillingley B., Mann A. J., Kalinova M. et al. Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults. Nat Med. 2022 May; 28 (5): 1031–1041. https://doi:10.1038/s41591-022-01780-9Killingley B., Mann A. J., Kalinova M. et al. Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults. Nat Med. 2022 May; 28 (5): 1031–1041. https://doi:10.1038/s41591-022-01780-9Butowt R., Bilinska K., von Bartheld C. S. Olfactory dysfunction in COVID-19: new insights into the underlying mechanisms. Trends Neurosci. 2023 Jan; 46 (1): 75–90. https://doi:10.1016/j.tins.2022.11.003. Epub 2022 Nov 16.Butowt R., Bilinska K., von Bartheld C. S. Olfactory dysfunction in COVID-19: new insights into the underlying mechanisms. Trends Neurosci. 2023 Jan; 46 (1): 75–90. https://doi:10.1016/j.tins.2022.11.003. Epub 2022 Nov 16.von Bartheld C. S., Hagen M. M., Butowt R. Prevalence of Chemosensory Dysfunction in COVID-19 Patients: A Systematic Review and Meta-analysis Reveals Significant Ethnic Differences. ACS Chem Neurosci. 2020 Oct 7; 11 (19): 2944–2961. https://doi:10.1021/acschemneuro.0c00460von Bartheld C. S., Hagen M. M., Butowt R. Prevalence of Chemosensory Dysfunction in COVID-19 Patients: A Systematic Review and Meta-analysis Reveals Significant Ethnic Differences. ACS Chem Neurosci. 2020 Oct 7; 11 (19): 2944–2961. https://doi:10.1021/acschemneuro.0c00460Радциг Е. Ю. О классификации обонятельных расстройств (по материалам отечественных и зарубежных документов) / Радциг Е. Ю., Осипова Е. П. Российская оториноларингология. 2019; 100 (3): 87–92.Radtsig E. Yu., Osipova E. P. About the classification of olfactory disorders (based on domestic and foreign documents). 2019; 100 (3): 87–92.Адамова А. С., Клочева Е. Г., Голдобин В. В. Качественные нарушения обоняния у пациентов со стойкой обонятельной дисфункцией, ассоциированной с COVID-19 / Адамова А. С., Клочева Е. Г., В. В. Голдобин. 2023.Adamova A. S., Klocheva E. G., Goldobin V. V. Qualitative olfactory disorders in patients with persistent olfactory dysfunction associated with COVID-19. 2023.Lefebvre C., Glanville J., Briscoe S. et al. Technical Supplement to Chapter 4: Searching for and selecting studies Cochrane Handbook for Systematic Reviews of Interventions Version 6.1 (updated September 2020). Cochrane, 2020. Available from training.cochrane.org/handbook.Lefebvre C., Glanville J., Briscoe S. et al. Technical Supplement to Chapter 4: Searching for and selecting studies Cochrane Handbook for Systematic Reviews of Interventions Version 6.1 (updated September 2020). Cochrane, 2020. Available from training.cochrane.org/handbook.Webster K. E., O'Byrne L., MacKeith S. et al. Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction. Cochrane Database Syst Rev. 2022 Sep 5; 9 (9): CD 013877. https://doi:10.1002/14651858.CD013877.pub3Webster K. E., O'Byrne L., MacKeith S. et al. Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction. Cochrane Database Syst Rev. 2022 Sep 5; 9 (9): CD 013877. https://doi:10.1002/14651858.CD013877.pub3Gerkin R. C., Ohla K, Veldhuizen M. G., et al. Recent Smell Loss Is the Best Predictor of COVID-19 Among Individuals With Recent Respiratory Symptoms. Chem Senses. 2021 Jan 1; 46–81. https://doi:10.1093/chemse/bjaa081Gerkin R. C., Ohla K, Veldhuizen M. G., et al. Recent Smell Loss Is the Best Predictor of COVID-19 Among Individuals With Recent Respiratory Symptoms. Chem Senses. 2021 Jan 1; 46–81. https://doi:10.1093/chemse/bjaa081Tragoonrungsea J., Tangbumrungtham N., Nitivanichsakul T. et al. Corticosteroid nasal irrigation as early treatment of olfactory dysfunction in COVID-19: A prospective randomised controlled trial. Clin Otolaryngol. 2023 Mar; 48 (2): 182–190. https://doi:10.1111/coa.14004.Tragoonrungsea J., Tangbumrungtham N., Nitivanichsakul T. et al. Corticosteroid nasal irrigation as early treatment of olfactory dysfunction in COVID-19: A prospective randomised controlled trial. Clin Otolaryngol. 2023 Mar; 48 (2): 182–190. https://doi:10.1111/coa.14004.Pisano M., Hilas O. Zinc and Taste Disturbances in Older Adults: A Review of the Literature. Consult Pharm. 2016 May; 31 (5): 267–70. https://doi:10.4140/TCP.n.2016.267Pisano M., Hilas O. Zinc and Taste Disturbances in Older Adults: A Review of the Literature. Consult Pharm. 2016 May; 31 (5): 267–70. https://doi:10.4140/TCP.n.2016.267Abdelmaksoud A. A., Ghweil A. A., Hassan M. H. et al. Olfactory Disturbances as Presenting Manifestation Among Egyptian Patients with COVID-19: Possible Role of Zinc. Biol Trace Elem Res. 2021 Nov; 199 (11): 4101–4108. https://doi:10.1007/s12011-020-02546-5Abdelmaksoud A. A., Ghweil A. A., Hassan M. H. et al. Olfactory Disturbances as Presenting Manifestation Among Egyptian Patients with COVID-19: Possible Role of Zinc. Biol Trace Elem Res. 2021 Nov; 199 (11): 4101–4108. https://doi:10.1007/s12011-020-02546-5Alexander T. H., Davidson T. M. Intranasal zinc and anosmia: the zinc-induced anosmia syndrome. Laryngoscope. 2006 Feb; 116 (2): 217–20. https://doi:10.1097/01.mlg.0000191549.17796.13Alexander T. H., Davidson T. M. Intranasal zinc and anosmia: the zinc-induced anosmia syndrome. Laryngoscope. 2006 Feb; 116 (2): 217–20. https://doi:10.1097/01.mlg.0000191549.17796.13Balmer J. E., Blomhoff R. Gene expression regulation by retinoic acid. J. Lipid Res. 2002 Nov; 43 (11): 1773–808. https://doi:10.1194/jlr.r100015-jlr200Balmer J. E., Blomhoff R. Gene expression regulation by retinoic acid. J. Lipid Res. 2002 Nov; 43 (11): 1773–808. https://doi:10.1194/jlr.r100015-jlr200Brann J. H., Firestein S. J. A lifetime of neurogenesis in the olfactory system. Front Neurosci. 2014 Jun 26; 8: 182. https://doi:10.3389/fnins.2014.00182Brann J. H., Firestein S. J. A lifetime of neurogenesis in the olfactory system. Front Neurosci. 2014 Jun 26; 8: 182. https://doi: 10.3389/fnins.2014.00182Paschaki M., Cammas L., Muta Y. et al. Retinoic acid regulates olfactory progenitor cell fate and differentiation. Neural Dev. 2013 Jul 5; 8: 13. https://doi:10.1186/1749-8104-8-13Paschaki M., Cammas L., Muta Y. et al. Retinoic acid regulates olfactory progenitor cell fate and differentiation. Neural Dev. 2013 Jul 5; 8: 13. https://doi:10.1186/1749-8104-8-13Kumaresan K., Bengtsson S., Sami S. et al. A double-blinded randomised controlled trial of vitamin A drops to treat post-viral olfactory loss: study protocol for a proof-of-concept study for vitamin A nasal drops in post-viral olfactory loss (APOLLO). Pilot Feasibility Stud. 2023 Oct 12; 9 (1): 174. https://doi:10.1186/s40814-023-01402-2Kumaresan K., Bengtsson S., Sami S. et al. A double-blinded randomised controlled trial of vitamin A drops to treat post-viral olfactory loss: study protocol for a proof-of-concept study for vitamin A nasal drops in post-viral olfactory loss (APOLLO). Pilot Feasibility Stud. 2023 Oct 12; 9 (1): 174. https://doi:10.1186/s40814-023-01402-2Reden J., Lill K., Zahnert T. et al. Olfactory function in patients with postinfectious and posttraumatic smell disorders before and after treatment with vitamin A: a double-blind, placebo-controlled, randomized clinical trial. Laryngoscope. 2012 Sep; 122 (9): 1906–9. https://doi:10.1002/lary.23405Reden J., Lill K., Zahnert T. et al. Olfactory function in patients with postinfectious and posttraumatic smell disorders before and after treatment with vitamin A: a double-blind, placebo-controlled, randomized clinical trial. Laryngoscope. 2012 Sep; 122 (9): 1906–9. https://doi:10.1002/lary.23405Ueha R., Kondo K., Kagoya R., et al. ACE 2, TMPRSS 2, and Furin expression in the nose and olfactory bulb in mice and humans. Rhinology. 2021 Feb 1; 59 (1): 105–109. https://doi:10.4193/Rhin20.324Ueha R., Kondo K., Kagoya R., et al. ACE 2, TMPRSS 2, and Furin expression in the nose and olfactory bulb in mice and humans. Rhinology. 2021 Feb 1; 59 (1): 105–109. https://doi:10.4193/Rhin20.324Barnes P. J. Theophylline. Pharmaceuticals (Basel). 2010 Mar 18; 3 (3): 725–747. https://doi:10.3390/ph3030725Barnes P. J. Theophylline. Pharmaceuticals (Basel). 2010 Mar 18; 3 (3): 725–747. https://doi:10.3390/ph3030725Neumann S., Bradke F., Tessier-Lavigne M. et al. Regeneration of sensory axons within the injured spinal cord induced by intraganglionic cAMP elevation. Neuron. 2002 Jun 13; 34 (6): 885–93. https://doi:10.1016/s0896–6273(02)00702-x. PMID: 12086637Neumann S., Bradke F., Tessier-Lavigne M. et al. Regeneration of sensory axons within the injured spinal cord induced by intraganglionic cAMP elevation. Neuron. 2002 Jun 13; 34 (6): 885–93. https://doi:10.1016/s0896–6273(02)00702-x. PMID: 12086637Lee J. J., Peterson A. M., Kallogjeri D. et al. Smell Changes and Efficacy of Nasal Theophylline (SCENT) irrigation: A randomized controlled trial for treatment of post-viral olfactory dysfunction. Am. J. Otolaryngol. 2022 Mar-Apr; 43 (2): 103299. https://doi:10.1016/j.amjoto.2021.103299Lee J. J., Peterson A. M., Kallogjeri D. et al. Smell Changes and Efficacy of Nasal Theophylline (SCENT) irrigation: A randomized controlled trial for treatment of post-viral olfactory dysfunction. Am. J. Otolaryngol. 2022 Mar-Apr; 43 (2): 103299. https://doi:10.1016/j.amjoto.2021.103299Philpott C. M., Erskine S. E., Clark A. et al. A randomised controlled trial of sodium citrate spray for non-conductive olfactory disorders. Clin Otolaryngol. 2017 Dec; 42 (6): 1295–1302. https://doi:10.1111/coa.12878Philpott C. M., Erskine S. E., Clark A. et al. A randomised controlled trial of sodium citrate spray for non-conductive olfactory disorders. Clin Otolaryngol. 2017 Dec; 42 (6): 1295–1302. https://doi:10.1111/coa.12878Hummel T., Heilmann S., Hüttenbriuk K. B. Lipoic acid in the treatment of smell dysfunction following viral infection of the upper respiratory tract. Laryngoscope. 2002 Nov; 112 (11): 2076–80. https://doi:10.1097/00005537-200211000-00031Hummel T., Heilmann S., Hüttenbriuk K. B. Lipoic acid in the treatment of smell dysfunction following viral infection of the upper respiratory tract. Laryngoscope. 2002 Nov; 112 (11): 2076–80. https://doi:10.1097/00005537-200211000-00031Lerner D. K., Garvey K. L., Arrighi-Allisan A. et al. Omega-3 Fatty Acid Supplementation for the Treatment of Persistent COVID-Related Olfactory Dysfunction. Am J Rhinol Allergy. 2023 Sep; 37 (5): 531–540. https://doi:10.1177/19458924231174799Lerner D. K., Garvey K. L., Arrighi-Allisan A. et al. Omega-3 Fatty Acid Supplementation for the Treatment of Persistent COVID-Related Olfactory Dysfunction. Am J Rhinol Allergy. 2023 Sep; 37 (5): 531–540. https://doi:10.1177/19458924231174799Cherobin G. B., Guimarães R. E.S., de Paula Gomes M. C. et al. Intranasal Insulin for the Treatment of Persistent Post-COVID-19 Olfactory Dysfunction. Otolaryngol Head Neck Surg. 2023 Sep; 169 (3): 719–724. https://doi:10.1002/ohn.352Cherobin G. B., Guimarães R. E.S., de Paula Gomes M. C. et al. Intranasal Insulin for the Treatment of Persistent Post-COVID-19 Olfactory Dysfunction. Otolaryngol Head Neck Surg. 2023 Sep; 169 (3): 719–724. https://doi:10.1002/ohn.352Vent J., Wang D. W., Damm M. Effects of traditional Chinese acupuncture in post-viral olfactory dysfunction. Otolaryngol Head Neck Surg. 2010 Apr; 142 (4): 505–9. https://doi:10.1016/j.otohns.2010.01.012Vent J., Wang D. W., Damm M. Effects of traditional Chinese acupuncture in post-viral olfactory dysfunction. Otolaryngol Head Neck Surg. 2010 Apr; 142 (4): 505–9. https://doi:10.1016/j.otohns.2010.01.012Dai Q., Pang Z., Yu H. Recovery of Olfactory Function in Postviral Olfactory Dysfunction Patients after Acupuncture Treatment. Evid Based Complement Alternat Med. 2016; 2016: 4986034.1–6. https://doi:10.1155/2016/4986034Dai Q., Pang Z., Yu H. Recovery of Olfactory Function in Postviral Olfactory Dysfunction Patients after Acupuncture Treatment. Evid Based Complement Alternat Med. 2016; 2016: 4986034.1–6. https://doi:10.1155/2016/4986034Damm M., Schmitl L., Müller C. A. et al. Diagnostik und Therapie von Riechstörungen. HNO. 2019 Apr; 67 (4): 274–281. https://doi:10.1007/s00106–019–0614-xDamm M., Schmitl L., Müller C. A. et al. Diagnostik und Therapie von Riechstörungen. HNO. 2019 Apr; 67 (4): 274–281. https://doi:10.1007/s00106–019–0614-xWhitcroft K. L., Hummel T. Clinical Diagnosis and Current Management Strategies for Olfactory Dysfunction: A Review. JAMA Otolaryngol Head Neck Surg. 2019 Sep1; 145 (9): 846–853. https://doi:10.1001/jamaoto.2019.1728Whitcroft K. L., Hummel T. Clinical Diagnosis and Current Management Strategies for Olfactory Dysfunction: A Review. JAMA Otolaryngol Head Neck Surg. 2019 Sep1; 145 (9): 846–853. https://doi:10.1001/jamaoto.2019.1728

The authors declare that there are no conflicts of interest present.